Hemorrhagic acquired factor XIII (13) deficiency and acquired hemorrhaphilia 13 revisited

Seminars in Thrombosis and Hemostasis

Volumn 37, Issue 4, 2011, Pages 382-388

  Ichinose, Akitada ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Acquired bleeding tendency; autoantibody; decreased production; increased consumption; protein crosslinking enzyme

Indexed keywords

ALPHA 2 ANTIPLASMIN; APROTININ; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 13 ANTIBODY; BLOOD CLOTTING FACTOR 13 CONCENTRATE; BLOOD CLOTTING FACTOR 13A; BLOOD CLOTTING FACTOR 13B; CORTICOSTEROID; CYCLOPHOSPHAMIDE; FIBRIN; FRESH FROZEN PLASMA; PROTEIN ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; RITUXIMAB; TRANEXAMIC ACID; UNCLASSIFIED DRUG;

ACQUIRED HEMORRHAPHILIA 13; ANEMIA; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BLOOD CLOTTING TIME; BRAIN HEMORRHAGE; CONGENITAL BLOOD CLOTTING DISORDER; CRYOPRECIPITATE; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE TRANSFUSION; HEMORRHAGIC ACQUIRED FACTOR XIII; HEMORRHAGIC AQCUIRED FACTOR XIII DEFICIENCY; HEMOSTASIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INDEL MUTATION; JAPANESE; PARTIAL THROMBOPLASTIN TIME; PATHOPHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREVALENCE; PRIORITY JOURNAL; PROTHROMBIN TIME; REVIEW; SCREENING TEST; SUBSTITUTION THERAPY; THROMBOCYTE COUNT; THROMBOPHILIA; WESTERN BLOTTING;

FACTOR XIII; FACTOR XIII DEFICIENCY; HEMOPHILIA A; HEMORRHAGIC DISORDERS; HUMANS;

EID: 79961066578     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0031-1276587     Document Type: Review

References (22)

1. Brinkhous K M. A short history of hemophilia, with some comments on the word Hemophilia Hemker H C. Brinkhous K M. eds. Handbook of Hemophilia. New York, NY Excerpta Medica 1975 3-20
2. Boggio L N., Green D. Acquired hemophilia. Rev Clin Exp Hematol 2001 5 4 389-404 quiz 431 (Pubitemid 34947697)
3. Collins P W., Hirsch S, Baglin T P. et al, UK Haemophilia Centre Doctors' Organisation. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. Blood 2007 109 5 1870-1877 (Pubitemid 46348182)
4. Loland L. Acquired inhibitors of fibrin stabilization: a class of hemorrhagic disorders of diverse origins. In: Green D ed. Anticoagulants: Physiologic, Pathologic & Pharmacologic. Boca Raton, FL CRC Press 1994 169-191
5. Egbring R, Kröniger A, Seitz R. Erworbene Inhibitoren gegen Faktor XIII. Hamostaseologie 1996 16 174-179 (Pubitemid 26335642)
6. Lorand L, Losowsky M S., Miloszewski K J. Human factor XIII: fibrin-stabilizing factor. Prog Hemost Thromb 1980 5 245-290
7. Ichinose A. Extracellular transglutaminase: factor XIII. Prog Exp Tumor Res 2005 38 192-208
8. AbdAlla S, Lother H, Langer A, el Faramawy Y, Quitterer U. Factor XIIIA transglutaminase crosslinks AT1 receptor dimers of monocytes at the onset of atherosclerosis. Cell 2004 119 3 343-354 (Pubitemid 39423837)
9. Kasahara K, Souri M, Kaneda M, Miki T, Yamamoto N, Ichinose A. Impaired clot retraction in factor XIII A subunit-deficient mice. Blood 2010 115 6 1277-1279
10. Ichinose A, Asahina T, Kobayashi T. Congenital blood coagulation factor XIII deficiency and perinatal management. Curr Drug Targets 2005 6 5 541-549 (Pubitemid 41051858)
11. Seitz R, Duckert F, Lopaciuk S, Muszbek L, Rodeghiero F, Seligsohn U, Study Group. ETRO Working Party on Factor XIII questionnaire on congenital factor XIII deficiency in Europe: status and perspectives. Semin Thromb Hemost 1996 22 5 415-418 (Pubitemid 27050711)
12. Gerlach R, Raabe A, Zimmermann M, Siegemund A, Seifert V. Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures. Surg Neurol 2000 54 3 260-264 discussion 264-265
13. Korte W F. F. XIII in perioperative coagulation management. Best Pract Res Clin Anaesthesiol 2010 24 1 85-93
14. Ivaskevicius V, Biswas A, Loreth R et al. Mutations affecting disulphide bonds contribute to a fairly common prevalence of F13B gene defects: results of a genetic study in 14 families with factor XIII B deficiency. Haemophilia 2010 16 4 675-682
15. Ajzner E, Schlammadinger A, Kerényi A et al. Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency. Blood 2009 113 3 723-725
16. Ajzner E, Muszbek L. Kinetic spectrophotometric factor XIII activity assays: the subtraction of plasma blank is not omissible [corrected]. J Thromb Haemost 2004 2 11 2075-2077
17. Caudill J S., Nichols W L., Plumhoff E A. et al. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma. Transfusion 2009 49 4 765-770
18. Ishida F, Okubo K, Ito T, Okumura N, Souri M, Ichinose A. Spontaneous regression of the inhibitor against the coagulation factor XIII A subunit in acquired factor XIII deficiency. Thromb Haemost 2010 104 6 1284-1285
19. Ballerini G, Guerra S, Rodeghiero F, Castaman G. A contribution to the pathology of acquired plasma factor XIII deficiency. Semin Thromb Hemost 1985 11 (4) 357-361 (Pubitemid 16244769)
20. Egbring R, Kröniger A, Seitz R. Factor XIII deficiency: pathogenic mechanisms and clinical significance. Semin Thromb Hemost 1996 22 5 419-425 (Pubitemid 27050712)
21. Ichinose A, Souri M. on behalf of the Japanese Collaborative Research Group on Acquired haemorrhaphilia due to factor XIII deficiency. As many as 12 cases with haemorrhagic acquired factor XIII deficiency due to its inhibitors were recently found in Japan. Thromb Haemost 2011 105 5 925-927
22. Jennings I, Kitchen S, Woods T A., Preston F E., UK NEQAS. Problems relating to the laboratory diagnosis of factor XIII deficiency: a UK NEQAS study. J Thromb Haemost 2003 1 12 2603-2608